Deactivates 99%+ of Coronavirus & Influenza in Minutes with Added 99%+ Filtration Protection

Ultimate protection for you, your family & everyone!​

3-PLY Adult Masks Style #V3
ASTM Level 3 Grade

Viracide’s proprietary coating deactivates 99%+ of Coronavirus + Influenza in minutes!

3-PLY Kids Masks Style #V3K
ASTM Level 3 Grade

Can be customized with Viracide coating in different colors, brands, and characters. Volume prices are available upon request.

KN95 Adult Masks
Style #VKN95
ASTM Level 3 Grade

All Viracide KN95 Masks (V-KN95 Mask) provides enhanced 98% Nano filtration surpassing N95 standards with the added protection of Viracide full surface coating.

3-PLY Adult Masks
Style #V3
ASTM Level 3 Grade

Viracide’s proprietary coating deactivates 99%+ of Coronavirus + Influenza in minutes!

3Ply_VG_green mask
3Ply_VG_grey mask
3Ply_VG_blue mask

3-PLY Kids Masks
Style #V3K
ASTM Level 3 Grade

Can be customized with Viracide coating in different colors, brands, and characters. Volume prices are available upon request.
Not Yet Available in the U.S.

KN95 Adult Masks
Style #VKN95
ASTM Level 3 Grade

All Viracide KN95 Masks (V-KN95 Mask) provide enhanced 99%+ filtration surpassing N95 standards with the added protection of Viracide full surface coating.
Not Yet Available in the U.S.

Viracide Masks are the ONLY face Covering masks in the market that DEACTIVATE Coronavirus + Influenza in minutes, and verified by third party test labs. Viracide Masks are ASTM Level 3 Grade.

Standard 3-PLY MaskViracide Mask -V3
Deactivates 99% of Coronavirus &
Influenza in Minutes
NoYes
Antibacterial ShieldNoYes
Filtration45%-78%99%+
Proprietary Homeopathic scentNoYes
Self-Disinfecting Touch SurfaceNoYes
Level 3 ASTM SpecificationsNoYes
Individually Wrapped for SafetyNoYes
DisposableYesYes

V3 Viracide Masks are produced in an FDA Registered Factory and an ISO 9001 & ISO 13485 certified factory to uphold maximum quality standards. This mask is in the process of being evaluated by the FDA for emergency use authorization. Though filtration is greater than  N95 standards the V3 is not a substitute for N95. Virus Deactivation Testing provided by FDA approved Situ BioScience Labs USA and Filtration testing provided by 3rd Party Test Labs.

Product Packaging V3

Adult Mask Shipping Specifications
One (1) product box has 30 masks
One (1) carton has 40 product boxes = 1,200 masks
One (1) pallet has 12 cartons (3 cartons high) = 14,400 masks
One (1) 40 ft. container = 50 pallets
One (1) full container = 720,000 masks

SKUDESCRIPTIONCOSTAVAILABILITY
1SM-V3-3030 Count$January 2021Jan
2021
2SM-V3-2K1,200 count$January 2021Jan
2021

Viracide’s V-KN95 includes all the same Coronavirus and Influenza deactivating features as the Viracide 3-Ply masks, supplying the same protection and comfort of traditional N95 masks on the market with enhanced 99%+ filtration.
Not Yet Available in the U.S.

Standard N95 MaskViracide Mask-V-KN95
Deactivates 99% of Coronavirus
& Influenza in Minutes
NoYes
Antibacterial ShieldNoYes
Filtration95%99%+
Proprietary Homeopathic scentNoYes
Self-Disinfecting Touch SurfaceNoYes
Level 3 ASTM SpecificationsYesYes
Individually Wrapped for SafetyNoYes
DisposableYesYes

VIRACIDE V3 Mask Data Modeling*

Dr. Marya Ghazipura is a renowned epidemiologist and biostatistician at New York University Langone Health. She is currently serving on the NYC COVID-19 Scientific Advisory Council. She has also collaborated with and consulted for a number of industries, including numerous international medical societies, government agencies such as NASA and the Canadian Ministry of Health, and large pharmaceutical companies. Dr. Ghazipura developed an epidemiological model to assess how the introduction of a mask with significant viral-killing properties (95%) as well as a reliable high filtration-rate (98%) would affect the present infection rate of COVID-19 in each U.S. state. This model was constructed based on present mask adherence and transmissibility rates by state, assessing how the number of new cases per day (both confirmed and predicted) will be impacted upon adoption of these masks.

Her conclusions, based on her modeling criteria, are as follows:

  • 80% of states (40 states) will be able to reduce their number of new cases per day by 50% in 100 days or less.

  • 92% of states (46 states) will be able to reduce their number of new cases per day by 50% in 300 days or less.

If current trends are to continue, until an effective vaccination or therapeutic becomes widely available and is adopted, cases per day are expected to continue to increase across the country.

*Marya Ghazipura, PhD, MS
Epidemiologist and Biostatistician
NYU Langone Health
NYC COVID-19 Scientific Advisory Council

CONTACT US

SmartMask Technology LLC

Corporate Headquarters
630 9th Ave, Suite 1411
New York, NY 10036

Research Center
107 Woody Drive
Butler, PA 16001

info@smartmasktechnology.com

Get notified about Viracide Mask Products